News

Real-time insights are a topic we and many others have discussed before. Being able to see immediately what works and what does not work is an incredible tool for organizations; especially when it comes to areas like patient experience and revenue cycle management. But how do we get these real-time insights? New tools and technologies are constantly being developed and improved in the world of healthcare. So, how do you know which ones you need to get your desired results?

In search of those answers, we reached out to our incredible Healthcare IT Today Community to ask — what tools or technologies are most effective in providing real-time insights into financial performance and key RCM metrics? The following is what they had to share.

WASHINGTON, D.C. – July 8, 2025 – AGS Health^®, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., has been named the top mid-cycle RCM outsourcing vendor for  2025 by Black Book Research, the healthcare industry's independent source for crowdsourced IT and outsourcing performance insights. The list of highest-rated RCM outsourcing vendors across the front-end, mid-cycle, back-end, and end-to-end service segments was based on 18 RCM-focused key performance indicators, including innovation, ROI contribution, staffing quality, automation readiness, operational outcomes, and responsiveness.

Driven by increased data consumption, the rapid uptick in cloud computing and hybrid cloud models, and emerging trends toward decentralization and edge computing, the U.S. data center market is projected to exceed $613 billion over the next decade. The heightened demand for AI-related data centers also comes into play, driving $31.5 billion in annualized spending on new data center construction and pushing the development pipeline to nearly 50 million square feet.

Behind the surge in data center popularity is a desire for greater cybersecurity than many organizations can provide in-house, putting pressure on center operators to provide secure, uninterrupted large-scale operations. It’s a particularly thorny challenge as bad actors increasingly set their sights on data centers and the immense volume of valuable information they hold.

Healthcare industry stakeholders made their case to leaders in President Donald Trump's health department last week about the need to improve the nation's health information technology infrastructure.

The request for information garnered just over 1,300 comments from trade groups, provider and hospital associations, individual companies, payers, patients and providers. The comment letters spanned the gamut of traditional health IT issues, such as issues with the Trusted Exchange Framework and Common Agreement (TEFCA) and weak enforcement of information blocking rules.

Providers, payers and health tech vendors have laid out a long to-do list for federal regulators on how the administration can optimize technology in healthcare.

The EHR Association shared its feedback on two NPRMs recently: to ASTP/ONC regarding the 2025 Standards Version Advancement Process (SVAP), and to CMS regarding the FY 2026 IPPS proposed rule (CMS–1833–P).

Health IT Answers»

The American Hospital Association, EHR Association, Premier, WEDI and ATA have weighed in on HHS’ request for comment about digital health tools for Medicare beneficiaries, and on the current state of interoperability and health IT infrastructure.

This past month, the Centers for Medicare and Medicaid Services and the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology put out a request for information from the broader healthcare and health IT community.

This past month, the Centers for Medicare and Medicaid Services and the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology put out a request for information from the broader healthcare and health IT community.

The goal, for an HHS newly restructured under Robert F. Kennedy, Jr., was to gather data to help "inform CMS and ASTP/ONC efforts to lead infrastructure progress," boosting Medicare beneficiaries' access to tools that will help them make better health decisions, and "increasing data availability for all stakeholders contributing to health outcomes."

Trust is critical in healthcare, not only trust between patients and providers but also trust in the health information used to make clinical decisions. Health information must be accurate, reliable, and complete. Unfortunately, data is inherently dirty. AHIMA estimates that 5-10% of patient records are duplicates, and some hospitals report duplicate rates as high as 22%. Meanwhile, one study found that 50% of patient notes are duplicated.

Even the most advanced AI-enabled automation technologies can’t fully resolve incorrect or incomplete duplicate patient records and other integrity issues. Matching algorithms can reduce human error, enhance care quality, and minimize the risk of misidentification, misdiagnoses, and improper or duplicative treatment. However, today’s EHRs lack sufficiently advanced matching algorithms, as their effectiveness depends on the underlying technology platform.

Healthcare finance executives face an intensifying storm of audits, denials, and clawbacks that threaten their organization’s financial stability. Couple that with an environment of heightened regulatory and payer scrutiny, and it becomes clear that proactive risk monitoring and AI-driven compliance strategies are no longer optional—they are imperative.

NeuroEM Therapeutics, an award-winning clinical-stage biotechnology research company pioneering the use of radio frequencies to reverse Alzheimer’s disease, has closed initial rounds totaling $1.33 million of a $5 million equity raise with BlueLake.vc.

The Series A round supports continued progress toward commercialization of NeuroEM’s Transcranial Electromagnetic Treatment (TEMT-RF) to prevent and treat cognitive decline caused by aging or Alzheimer’s and other neurodegenerative diseases.

NeuroEM Therapeutics company, a clinical-stage biotechnology company pioneering radio frequency-based treatments for Alzheimer's disease, has secured $1.33 million in initial funding rounds as part of a larger $5 million Series A equity raise with BlueLake.vc. The investment will accelerate the commercialization of the company's Transcranial Electromagnetic Treatment (TEMT-RF) drug technology, a drug-free approach to preventing and treating cognitive decline disease.

Tampa-based NeuroEM Therapeutics has closed $1.33 million in early rounds of a $5million Series A raise, led by Blue Lake Ventures, to fund the commercialization of its non-invasive brain health device that targets Alzheimer’s and cognitive decline.

WASHINGTON, D.C. – June 11, 2025 – AGS Health^® CEO Patrice Wolfe has been named to the Becker’s Hospital Review list of “Women in Health IT to Know” in 2025. The annual list recognizes women who are harnessing the power of health IT to help shape the future of the healthcare industry.

Wolfe has been at the helm of AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., for nearly six years. During her tenure, the company has evolved into a market leader in technology-led RCM solutions, strengthening its capabilities through strategic acquisitions and the organic development of proprietary technologies.

WASHINGTON, D.C. – May 15, 2025 – AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., announced today its expansion into Mexico with the opening of an office in Guadalajara. Taking advantage of the region’s growing technology presence and a skilled medical, legal, and engineering workforce, AGS Health will hire more than 150 team members to provide Clinical Administrative Services from the new location.